Victrex (LON:VCT) had its price target boosted by Liberum Capital from GBX 2,440 ($32.84) to GBX 2,770 ($37.28) in a research report report published on Monday morning. They currently have a buy rating on the stock.

VCT has been the subject of several other research reports. UBS assumed coverage on shares of Victrex in a research report on Monday, August 21st. They issued a neutral rating and a GBX 2,050 ($27.59) target price for the company. Berenberg Bank raised shares of Victrex to a buy rating and lifted their price target for the company from GBX 2,000 ($26.92) to GBX 2,600 ($34.99) in a report on Wednesday, September 6th. Deutsche Bank lifted their price target on shares of Victrex from GBX 2,050 ($27.59) to GBX 2,200 ($29.61) and gave the company a hold rating in a report on Thursday, September 28th. J P Morgan Chase & Co lifted their price target on shares of Victrex from GBX 1,800 ($24.23) to GBX 2,150 ($28.94) and gave the company a neutral rating in a report on Tuesday, September 5th. Finally, Peel Hunt lowered shares of Victrex to a hold rating and set a GBX 2,300 ($30.96) price target for the company. in a report on Tuesday, October 31st. Eight analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has an average rating of Hold and an average target price of GBX 2,276.80 ($30.64).

Shares of Victrex (VCT) opened at GBX 2,557 ($34.41) on Monday. Victrex has a 1 year low of GBX 1,815 ($24.43) and a 1 year high of GBX 2,607 ($35.09).

The company also recently announced a dividend, which will be paid on Friday, February 16th. Shareholders of record on Thursday, February 1st will be paid a dividend of GBX 109.60 ($1.48) per share. This represents a yield of 4.31%. This is a positive change from Victrex’s previous dividend of $12.20. The ex-dividend date of this dividend is Thursday, February 1st.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/12/victrex-vct-given-new-gbx-2770-price-target-at-liberum-capital.html.

Victrex Company Profile

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex plc and related companies with MarketBeat.com's FREE daily email newsletter.